Ori Spotlight
By Ori Biotech
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Ori Biotech
Category: Life Sciences
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 1
Reviews: 0
Episodes: 36
Description
Ori Spotlight covers the latest in cell and gene therapy.
Jason C. Foster, Ori Biotech CEO will be talking to leaders from across the industry to find out more about how we can break down the barriers and seize the opportunities to make sure that every patient has access to life-changing treatments.
Connect with Ori Biotech to learn more about partnering to pioneer innovative technologies in CGT manufacturing that bring CGT products to market at commercial scale at decreased costs while increasing throughput and improving quality: www.oribiotech.com/connect
| Episode | Date |
|---|---|
|
Joe DePinto: Bridging growth and accessibility within CGTs
|
Apr 22, 2024 |
|
Matthew Hewitt: scalability is a collective problem
|
Mar 11, 2024 |
|
Adam Siebert & Jeff Holder: early investment in manufacturing is critical for CGT accessibility
|
Feb 19, 2024 |
|
Jim Faulkner: Why unaffordable therapy success is worse than failure...
|
Jan 29, 2024 |
|
Sanjay Srivastava: Are CGTs Developing into a Commercial Dead-End?
|
Jan 08, 2024 |
|
Tim Hunt: leading CGT with education and community
|
Jul 18, 2023 |
|
Vered Caplan: why yesterday’s thinking is not going to solve today’s problems
|
Jun 27, 2023 |
|
Daniel Gibson: improving patient access to cell therapies
|
Jun 13, 2023 |
|
Dr Betty Woo: why it’s important to take calculated risks early in your career
|
May 09, 2023 |
|
John Lee: “Cellicon Valley” accelerates development and manufacturing of innovative cell & gene therapies
|
Apr 18, 2023 |
|
Amy Kappen: connecting CAR-T families with The Best Day Ever Foundation
|
Mar 28, 2023 |
|
Philip Vanek – CTO, Gamma Biosciences
|
Nov 29, 2022 |
|
Matthew Durdy - CEO, CGT Catapult
|
Nov 08, 2022 |
|
Jonathan Hay – Partner, Delin Ventures
|
Oct 25, 2022 |
|
Elliot Menschik – Chief Digital Officer, Resilience
|
Oct 11, 2022 |
|
The Whitehead and Jones Families, Patient Advocates
|
Sep 27, 2022 |
|
Jason Bock – CEO, Cell Therapy Manufacturing Center (CTMC)
|
Sep 14, 2022 |
|
Isabelle Rivière – Director of Cell Therapy and Cell Engineering Laboratory, Memorial Sloan-Kettering Cancer Center (MSKCC)
|
Aug 31, 2022 |
|
Stuart Milne - Chief Technology Officer, Ori Biotech
|
Aug 16, 2022 |
|
Mike Paglia - Chief Operating Officer, ElevateBio
|
Jul 12, 2022 |
|
Kevin Kyle and Carol Houts - Germfree
|
Jun 14, 2022 |
|
Jo Anne Valentino - Chief Operating Officer, Minaris Regenerative Medicine
|
Apr 19, 2022 |
|
John Connolly - Chief Scientific Officer, Parker Institute for Cancer Immunotherapy
|
Mar 16, 2022 |
|
Mike Nicholson & Matt Haines - Inceptor Bio
|
Feb 23, 2022 |
|
Adam Wieschhaus and Shaan Gandhi - Directors, Northpond Ventures
|
Feb 01, 2022 |
|
Paul Meister - Partner, Novalis LifeSciences
|
Jan 21, 2022 |
|
Dr. Farlan Veraitch - Co-Founder and Chief Scientific Officer, Ori Biotech
|
Nov 16, 2021 |
|
Dr. Qasim Rafiq - Associate Professor of Cell and Gene Therapy Bioprocessing, University College London
|
Oct 12, 2021 |
|
Robert Preti, PhD - Strategic Advisor, Ori Biotech
|
Sep 01, 2021 |
|
Dr. Annalisa Jenkins - Strategic Advisor, Ori Biotech
|
Aug 18, 2021 |
|
Dennis Powers - Vice President of Business Development & Sales Engineering, G-CON Manufacturing
|
Jul 27, 2021 |
|
Rahul Singhvi - Co-founder and CEO, Resilience
|
Jul 13, 2021 |
|
Deanna M. Petersen - Chief Business Officer, AVROBIO
|
Jun 15, 2021 |
|
Bruce Levine PHD - Professor in Cancer Gene Therapy, University of Pennsylvania
|
Jun 02, 2021 |
|
Tom & Emily Whitehead with Vincent Carrano - Emily Whitehead Foundation
|
May 06, 2021 |
|
Anthony Davies - Founder & CEO, Dark Horse Consulting
|
Apr 19, 2021 |